Skip to main content

Table 3 Outcomes of febrile neutropenic patients

From: Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country

Variable

n (%)

Need for oxygen therapy

 

 Yes

20 (13.3

 No

130 (86.7)

Mechanical ventilation

 

 Yes

8 (5.3)

 No

142 (94.7)

Shock

 

 Yes

14 (9.3)

 No

136 (90.7)

ICU admission

 

 Yes

14 (9.3)

 No

136 (90.7)

Renal dysfunction

 

 Yes

25 (16.7)

 No

125 (83.3)

Hepatic dysfunction

 

 Yes

11 (7.3)

 No

139 (92.7)

MASCC score, median and IQR

20 (18–22)

MASCC score category

 

 Less than 21

96 (64)

 Greater than or equal to 21

54 (36)

Outcome

 

 Discharged

141 (94)

 Died

9 (6)

  1. ICU, intensive care unit; MASCC, The Multinational Association for Supportive Care in Cancer, IQR, interquartile range